OUTSEE LIMITED

Active Cambridge

Research and experimental development on biotechnology

7 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
O

OUTSEE LIMITED

Research and experimental development on biotechnology

Founded 30 Sept 2022 Active Cambridge, England 7 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 27 Jan 2026 Next due 30 Jun 2027 12 months remaining
Confirmation Submitted 19 Oct 2025 Next due 13 Oct 2026 4 months remaining
Net assets £2M £2M 2025 year on year
Total assets £2M £1M 2025 year on year
Total Liabilities £35K £232K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O Wework 50-60 Station Road Cambridge CB1 2JH England

Website

www.example.com

Full company profile for OUTSEE LIMITED (14388773), an active life sciences and medical technology company based in Cambridge, England. Incorporated 30 Sept 2022. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Oct → 30 Sept 2025
Type micro-entity
Next accounts 30 Sept 2026
Due by 30 Jun 2027 12 months remaining

Balance Sheet & P&L (2023–2025)

Cash in Bank

N/A

Net Assets

£1.62M

Increased by £1.61M (+46448%)

Total Liabilities

£35.22k

Decreased by £231.91k (-87%)

Turnover

N/A

Employees

7

Increased by 1 (+17%)

Debt Ratio

2%

Decreased by 97 (-98%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Sept Year End
2024
30 Sept Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 688,823 Shares £2.49m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
17 Jul 2025191,587£694k£3.62
13 Dec 20245,421£0£0
13 Dec 2024400,551£1.45m£3.62
26 Jul 202491,264£350k£3.835

Officers

Officers

2 active 1 resigned
Status
Thomas VandersticheleDirectorBritishEngland2925 Jul 2024Active
Wallace, Thomas PaulDirectorBritishEngland6325 Jul 2024Active

Shareholders

Shareholders (7)

Julian Gough
63.1%
945,000
Ahren Ii Lp
18.5%
276,243

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Julian Gough

English

Active
Notified 30 Sept 2022
Residence England
DOB September 1974
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Mar 2026OfficersChange to director Mr Paul Wallace on 27 Mar 2026
19 Mar 2026OfficersTermination of Joanna Charlotte Antonia Green as director on 17 Mar 2026
19 Mar 2026OfficersAppointment of James Peter Lourensz as director on 17 Mar 2026
27 Jan 2026AccountsAnnual accounts made up to 30 Sept 2025
28 Nov 2025CapitalAllotment of shares (GBP 1.688823) on 26 Nov 2025
27 Mar 2026 Officers

Change to director Mr Paul Wallace on 27 Mar 2026

19 Mar 2026 Officers

Termination of Joanna Charlotte Antonia Green as director on 17 Mar 2026

19 Mar 2026 Officers

Appointment of James Peter Lourensz as director on 17 Mar 2026

27 Jan 2026 Accounts

Annual accounts made up to 30 Sept 2025

28 Nov 2025 Capital

Allotment of shares (GBP 1.688823) on 26 Nov 2025

Recent Activity

Latest Activity

Change to director Mr Paul Wallace on 27 Mar 2026

2 months ago on 27 Mar 2026

Termination of Joanna Charlotte Antonia Green as director on 17 Mar 2026

2 months ago on 19 Mar 2026

Appointment of James Peter Lourensz as director on 17 Mar 2026

2 months ago on 19 Mar 2026

Annual accounts made up to 30 Sept 2025

4 months ago on 27 Jan 2026

Allotment of shares (GBP 1.688823) on 26 Nov 2025

6 months ago on 28 Nov 2025